Skip Navigation

Drug Development, from Chemistry to Diagnostics and Therapies

Development of novel diagnostics and therapeutics requires expertise and technologies ranging from computational simulations, structural biology, pharmacology, medicinal chemistry and imagining, to clinical studies and academia-industry relations.


Team Members
Markus Seeliger,  Pharmacology (Lead)
Maurizio del Poeta, Microbiology & Immunology
Michael Airola, Biochemistry
John Haley, Pathology
Eszter Boros, Chemistry
Mark Slifstein, Psychiatry
Diane Fabel, Center for Biotechnology
OPD Rep: Karrie Gash